The Latest SPAC News and Rumors: March 22, 2023
by Marlena Haddad on 2023-03-22 at 11:34am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News:  Electriq Power signs $300M agreement, Zapp reveals production version of i300 Carbon Launch Edition, and White & Case sues Colonnade II


Electriq Power secures $300M to deploy solar + storage in California with ‘major U.S. clean energy company’

Energy storage system integrator Electriq Power signed a multi-year agreement with a “major U.S. clean-energy company,” for more than $300 million in financing to fund projects in California over the next 30 months, according to the company.

Electriq Power announced in November 2022 that it is being acquired by TLG Acquisition One Corp., a publicly traded special purpose acquisition company, and is going public. The transaction is expected to close during the first half of 2023, the combined company will operate under the name Electriq Power Holdings Inc. and will be led by existing Electriq management with Mike Lawrie joining the board as Chairman.

READ

Zapp Reveals Production Version of i300 Carbon Launch Edition

Zapp Electric Vehicles Limited, a UK-based high-performance two-wheel electric vehicle company, today revealed the production version of its limited-run i300 Carbon Launch Edition.

On November 22, 2022, Zapp and CIIG Capital Partners II, Inc., a U.S. publicly-listed blank check company (Nasdaq: CIIG), announced that they have entered into a definitive merger agreement.

READ

With no merger deal, failed SPAC faces lawsuit over legal fees

Law firm White & Case has sued a special purpose acquisition company for more than $8.2 million in legal fees, claiming it stiffed the firm after failing to consummate a planned $480 million merger and then announcing plans to wind down this month.

New York-founded White & Case sued former client Colonnade Acquisition Corp II and its directors in New York state court late Monday, arguing the firm will be “irreparably harmed” if the blank-check company liquidates and dissolves before paying the fees it owes.

READ


 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved